Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context
Summary: Background: Evidence on post-acute sequelae of SARS-CoV-2 (PASC) has shown inconsistent findings. This study aimed to generate coherent evidence on the post-acute sequelae of COVID-19 infection using electronic healthcare records across two regions. Methods: In this retrospective, multi-da...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | EClinicalMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537023001773 |
_version_ | 1797829100250857472 |
---|---|
author | Ivan Chun Hang Lam Carlos King Ho Wong Ran Zhang Celine Sze Ling Chui Francisco Tsz Tsun Lai Xue Li Esther Wai Yin Chan Hao Luo Qingpeng Zhang Kenneth Keng Cheung Man Bernard Man Yung Cheung Sydney Chi Wai Tang Chak Sing Lau Eric Yuk Fai Wan Ian Chi Kei Wong |
author_facet | Ivan Chun Hang Lam Carlos King Ho Wong Ran Zhang Celine Sze Ling Chui Francisco Tsz Tsun Lai Xue Li Esther Wai Yin Chan Hao Luo Qingpeng Zhang Kenneth Keng Cheung Man Bernard Man Yung Cheung Sydney Chi Wai Tang Chak Sing Lau Eric Yuk Fai Wan Ian Chi Kei Wong |
author_sort | Ivan Chun Hang Lam |
collection | DOAJ |
description | Summary: Background: Evidence on post-acute sequelae of SARS-CoV-2 (PASC) has shown inconsistent findings. This study aimed to generate coherent evidence on the post-acute sequelae of COVID-19 infection using electronic healthcare records across two regions. Methods: In this retrospective, multi-database cohort study, patients with COVID-19 aged 18 or above between April 1st 2020 and May 31st 2022 from the Hong Kong Hospital Authority (HKHA) and March 16th 2020 and May 31st 2021 from the UK Biobank (UKB) databases and their matched controls were followed for up to 28 and 17 months, respectively. Covariates between patients with COVID-19 and non-COVID-19 controls were adjusted using propensity score-based inverse probability treatment weighting. Cox proportional regression was used to estimate the hazard ratio (HR) of clinical sequelae, cardiovascular, and all-cause mortality 21 days after COVID-19 infection. Findings: A total of 535,186 and 16,400 patients were diagnosed with COVID-19 from HKHA and UKB, of whom 253,872 (47.4%) and 7613 (46.4%) were male, with a mean age (±SD) of 53.6 (17.8) years and 65.0 (8.5) years, respectively. Patients with COVID-19 incurred greater risk of heart failure (HR 1.82; 95% CI 1.65, 2.01), atrial fibrillation (1.31; 1.16, 1.48), coronary artery disease (1.32; 1.07, 1.63), deep vein thrombosis (1.74; 1.27, 2.37), chronic pulmonary disease (1.61; 1.40, 1.85), acute respiratory distress syndrome (1.89; 1.04, 3.43), interstitial lung disease (3.91; 2.36, 6.50), seizure (2.32; 1.12, 4.79), anxiety disorder (1.65; 1.29, 2.09), post-traumatic stress disorder (1.52; 1.23, 1.87), end-stage renal disease (1.76; 1.31, 2.38), acute kidney injury (2.14; 1.69, 2.71), pancreatitis (1.42; 1.10, 1.83), cardiovascular (2.86; 1.25, 6.51) and all-cause mortality (4.16; 2.11, 8.21) mortality during their post-acute phase of infection. Interpretation: The consistent greater risk of PASC highlighted the need for sustained multi-disciplinary care for COVID-19 survivors. Funding: Health Bureau, The Government of the Hong Kong Special Administrative Region, Collaborative Research Fund, The Government of the Hong Kong Special Administrative Region and AIR@InnoHK, administered by the Innovation and Technology Commission, The Government of the Hong Kong Special Administrative Region. |
first_indexed | 2024-04-09T13:15:03Z |
format | Article |
id | doaj.art-ced76f723438478e92eebba33007857e |
institution | Directory Open Access Journal |
issn | 2589-5370 |
language | English |
last_indexed | 2024-04-09T13:15:03Z |
publishDate | 2023-06-01 |
publisher | Elsevier |
record_format | Article |
series | EClinicalMedicine |
spelling | doaj.art-ced76f723438478e92eebba33007857e2023-05-12T04:17:01ZengElsevierEClinicalMedicine2589-53702023-06-0160102000Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in contextIvan Chun Hang Lam0Carlos King Ho Wong1Ran Zhang2Celine Sze Ling Chui3Francisco Tsz Tsun Lai4Xue Li5Esther Wai Yin Chan6Hao Luo7Qingpeng Zhang8Kenneth Keng Cheung Man9Bernard Man Yung Cheung10Sydney Chi Wai Tang11Chak Sing Lau12Eric Yuk Fai Wan13Ian Chi Kei Wong14Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, ChinaDepartment of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaLaboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; School of Nursing, Li Ka Shing Faculty of Medicine, The University of Hong Kong SAR, Hong Kong, China; School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; Department of Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China; The University of Hong Kong Shenzhen Institute of Research and Innovation, Hong Kong SAR, ChinaDepartment of Social Work and Social Administration, The University of Hong Kong, Hong Kong SAR, China; The Hong Kong Jockey Club Centre for Suicide Research and Prevention, The University of Hong Kong, Hong Kong SAR, China; Sau Po Centre on Ageing, The University of Hong Kong, Hong Kong, ChinaSchool of Data Science, City University of Hong Kong, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; Research Department of Practice and Policy, School of Pharmacy, University College London, United KingdomDepartment of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Research Centre of Heart, Brain, Hormone and Healthy Aging, The University of Hong Kong, Queen Mary Hospital, Pok Fu Lam, Hong Kong, ChinaDivision of Nephrology, Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, ChinaDivision of Rheumatology and Clinical Immunology, Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, ChinaCentre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Department of Family Medicine and Primary Care, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; Corresponding author. 3/F, Ap Lei Chau Clinic, 161 Ap Lei Chau Main Street, Ap Lei Chau, Hong Kong SAR, China.Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Laboratory of Data Discovery for Health (D24H), Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China; Aston Pharmacy School, Aston University, Birmingham, United Kingdom; Corresponding author. L2-57, Laboratory Block, 21 Sassoon Road, Pokfulam, Hong Kong SAR, China.Summary: Background: Evidence on post-acute sequelae of SARS-CoV-2 (PASC) has shown inconsistent findings. This study aimed to generate coherent evidence on the post-acute sequelae of COVID-19 infection using electronic healthcare records across two regions. Methods: In this retrospective, multi-database cohort study, patients with COVID-19 aged 18 or above between April 1st 2020 and May 31st 2022 from the Hong Kong Hospital Authority (HKHA) and March 16th 2020 and May 31st 2021 from the UK Biobank (UKB) databases and their matched controls were followed for up to 28 and 17 months, respectively. Covariates between patients with COVID-19 and non-COVID-19 controls were adjusted using propensity score-based inverse probability treatment weighting. Cox proportional regression was used to estimate the hazard ratio (HR) of clinical sequelae, cardiovascular, and all-cause mortality 21 days after COVID-19 infection. Findings: A total of 535,186 and 16,400 patients were diagnosed with COVID-19 from HKHA and UKB, of whom 253,872 (47.4%) and 7613 (46.4%) were male, with a mean age (±SD) of 53.6 (17.8) years and 65.0 (8.5) years, respectively. Patients with COVID-19 incurred greater risk of heart failure (HR 1.82; 95% CI 1.65, 2.01), atrial fibrillation (1.31; 1.16, 1.48), coronary artery disease (1.32; 1.07, 1.63), deep vein thrombosis (1.74; 1.27, 2.37), chronic pulmonary disease (1.61; 1.40, 1.85), acute respiratory distress syndrome (1.89; 1.04, 3.43), interstitial lung disease (3.91; 2.36, 6.50), seizure (2.32; 1.12, 4.79), anxiety disorder (1.65; 1.29, 2.09), post-traumatic stress disorder (1.52; 1.23, 1.87), end-stage renal disease (1.76; 1.31, 2.38), acute kidney injury (2.14; 1.69, 2.71), pancreatitis (1.42; 1.10, 1.83), cardiovascular (2.86; 1.25, 6.51) and all-cause mortality (4.16; 2.11, 8.21) mortality during their post-acute phase of infection. Interpretation: The consistent greater risk of PASC highlighted the need for sustained multi-disciplinary care for COVID-19 survivors. Funding: Health Bureau, The Government of the Hong Kong Special Administrative Region, Collaborative Research Fund, The Government of the Hong Kong Special Administrative Region and AIR@InnoHK, administered by the Innovation and Technology Commission, The Government of the Hong Kong Special Administrative Region.http://www.sciencedirect.com/science/article/pii/S2589537023001773Post-acute sequelae of SARS-CoV-2PASCCOVID-19SARS-CoV-2 |
spellingShingle | Ivan Chun Hang Lam Carlos King Ho Wong Ran Zhang Celine Sze Ling Chui Francisco Tsz Tsun Lai Xue Li Esther Wai Yin Chan Hao Luo Qingpeng Zhang Kenneth Keng Cheung Man Bernard Man Yung Cheung Sydney Chi Wai Tang Chak Sing Lau Eric Yuk Fai Wan Ian Chi Kei Wong Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context EClinicalMedicine Post-acute sequelae of SARS-CoV-2 PASC COVID-19 SARS-CoV-2 |
title | Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context |
title_full | Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context |
title_fullStr | Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context |
title_full_unstemmed | Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context |
title_short | Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UKResearch in context |
title_sort | long term post acute sequelae of covid 19 infection a retrospective multi database cohort study in hong kong and the ukresearch in context |
topic | Post-acute sequelae of SARS-CoV-2 PASC COVID-19 SARS-CoV-2 |
url | http://www.sciencedirect.com/science/article/pii/S2589537023001773 |
work_keys_str_mv | AT ivanchunhanglam longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT carloskinghowong longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT ranzhang longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT celineszelingchui longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT franciscotsztsunlai longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT xueli longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT estherwaiyinchan longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT haoluo longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT qingpengzhang longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT kennethkengcheungman longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT bernardmanyungcheung longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT sydneychiwaitang longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT chaksinglau longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT ericyukfaiwan longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext AT ianchikeiwong longtermpostacutesequelaeofcovid19infectionaretrospectivemultidatabasecohortstudyinhongkongandtheukresearchincontext |